Cullen/Frost Bankers’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-500
Closed -$10K 1077
2022
Q1
$10K Sell
500
-750
-60% -$15.6K ﹤0.01% 941
2021
Q4
$32K Hold
1,250
﹤0.01% 829
2021
Q3
$34K Buy
+1,250
New +$35.8K ﹤0.01% 853

Other funds holding BMEZ

Cullen/Frost Bankers's BMEZ Position: Q2 2022 in Review

Cullen/Frost Bankers sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2022, closing a stake of 500 shares — an estimated $10K sold.

Cullen/Frost Bankers first reported a position in BMEZ in Q3 2021 and held it in 3 quarters. The position peaked at $34K in Q3 2021. 78 funds tracked by Wall St. Rank hold BMEZ as of Q2 2022.

  • Cullen/Frost Bankers reported no remaining BlackRock Health Sciences Trust II position as of Q2 2022 after selling out during the quarter.
  • Cullen/Frost Bankers sold 500 BlackRock Health Sciences Trust II shares in Q2 2022, an estimated $10K.
  • Cullen/Frost Bankers first reported a position in BlackRock Health Sciences Trust II in Q3 2021 and held it in 3 quarters.
  • Cullen/Frost Bankers's BlackRock Health Sciences Trust II position peaked at $34K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2022.

Based on Cullen/Frost Bankers's 13F filing for Q2 2022, filed 5 Aug 2022.